James David Clark Cvs Health Corp (CVS) insider trading activity

James David Clark is SVP, Cont & Chief Acct Officer of CVS HEALTH Corp. Currently has a direct ownership of 24,401 shares of CVS, which is worth approximately $1.91 Million. The most recent transaction as insider was on Mar 31, 2021, when has been sold 5,350 shares (Common Stock) at a price of $76.0 per share, resulting in proceeds of $406,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.4K

117.09% 3M change

190.7% 12M change

Total Value Held $1.91 Million

James David Clark Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2021	SELL Open market or private sale	$406,600 $76.0 p/Share	5,350 Reduced 42.48%	7,244 Common Stock
Mar 31 2021	BUY Exercise of conversion of derivative security	$397,452 $74.29 p/Share	5,350 Added 29.81%	12,594 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$76,919 $68.13 p/Share	1,129 Reduced 13.48%	7,244 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	13,113 Added 42.24%	17,930 Common Stock
May 26 2020	SELL Open market or private sale	$17,550 $65.0 p/Share	270 Reduced 5.61%	4,547 Common Stock
Apr 28 2020	SELL Open market or private sale	$405,210 $65.0 p/Share	6,234 Reduced 56.41%	4,817 Common Stock
Apr 01 2020	SELL Payment of exercise price or tax liability	$39,730 $58.34 p/Share	681 Reduced 5.67%	11,321 Common Stock

Apr 01 2020	BUY Grant, award, or other acquisition	$449,976 $58.34 p/Share	7,713 Added 27.63%	20,204 Common Stock (restricted)
Mar 30 2020	SELL Open market or private sale	$181,800 $60.0 p/Share	3,030 Reduced 23.69%	9,760 Common Stock
Mar 30 2020	BUY Exercise of conversion of derivative security	$165,226 $54.53 p/Share	3,030 Added 19.15%	12,790 Common Stock
Feb 28 2020	SELL Payment of exercise price or tax liability	$20,535 $59.18 p/Share	347 Reduced 3.43%	9,760 Common Stock
Feb 28 2020	BUY Grant, award, or other acquisition	$113,152 $59.18 p/Share	1,912 Added 11.49%	14,733 Common Stock (restricted)
Apr 01 2019	SELL Payment of exercise price or tax liability	$13,710 $54.19 p/Share	253 Reduced 2.69%	9,135 Common Stock
Apr 01 2019	BUY Grant, award, or other acquisition	$299,996 $54.19 p/Share	5,536 Added 28.64%	13,793 Common Stock (restricted)
Mar 01 2019	SELL Open market or private sale	$96,745 $58.14 p/Share	1,664 Reduced 19.45%	6,893 Common Stock
Mar 01 2019	BUY Exercise of conversion of derivative security	$74,996 $45.07 p/Share	1,664 Added 16.28%	8,557 Common Stock
Feb 28 2019	SELL Payment of exercise price or tax liability	$16,655 $57.83 p/Share	288 Reduced 3.26%	8,557 Common Stock
Feb 28 2019	BUY Grant, award, or other acquisition	$76,509 $57.83 p/Share	1,323 Added 12.71%	9,088 Common Stock (restricted)

JDC

James David Clark

SVP, Cont & Chief Acct Officer

Woonsocket, RI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Value

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS

Account